Toronto, Ontario--(Newsfile Corp. - le 10 janvier/January 2022) The common shares of Pharmala Biotech Holdings Inc. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Pharmala is focused on manufacture of Active Pharmaceutical Ingredients, of...